Clinical Trials Using Uridine Triacetate
Clinical trials are research studies that involve people. The clinical trials on this list are studying Uridine Triacetate. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Uridine Triacetate as Antidote for Patients at Excess Risk of 5-FU Toxicity Due to Overdosage or Impaired Elimination
The purpose of this study is to provide emergency treatment of adult and pediatric patients: - Following a fluorouracil or capecitabine overdose regardless of the presence of symptoms or - Who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous systems, and / or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and / or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration.
Location: Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire